Table 3.
The influence of discontinuation or continuation of antihypertensive drugs on physical performance in 78 patients who attended the frailty clinic at the National Center for Geriatrics and Gerontology, Obu, Japan.
| Physical performance measure | Discontinuation(n = 19) | Statistical significance | Continuation(n = 59) | Statistical significance |
|---|---|---|---|---|
| Total fall risk score | ||||
| First visit | 9.8 ± 3.8 | P = 0.27# | 10.2 ± 3.2 | P < 0.05# |
| 1-year follow-up visit | 8.7 ± 3.9 | 9.3 ± 3.6 | ||
| SPPB balance score | ||||
| First visit | 2.9 ± 1.4 | P < 0.05# | 3.6 ± 0.7 | P < 0.05# |
| 1-year follow-up visit | 3.6 ± 0.8 | 3.3 ± 1.0 | ||
| SPPB gait speed score | ||||
| First visit | 2.9 ± 1.1 | P < 0.05# | 3.2 ± 0.9 | P < 0.01# |
| 1-year follow-up visit | 3.4 ± 0.6 | 3.5 ± 0.8 | ||
| SPPB chair stand score | ||||
| First visit | 3.0 ± 1.4 | P = 0.27# | 3.1 ± 1.2 | P < 0.05# |
| 1-year follow-up visit | 3.3 ± 1.2 | 3.4 ± 1.0 | ||
| Total SPPB score | ||||
| First visit | 8.9 ± 3.1 | P < 0.05# | 9.9 ± 2.1 | P = 0.20# |
| 1-year follow-up visit | 10.4 ± 1.9 | 10.2 ± 2.1 | ||
| SMI (kg/m2) | ||||
| First visit | 7.2 ± 1.7 | P = 0.24# | 6.2 ± 1.0 | P = 0.15# |
| 1-year follow-up visit | 6.9 ± 1.1 | 6.3 ± 1.1 |
Data presented as mean ± SD.
SPPB, short physical performance battery; SMI, skeletal muscle index.
#Paired sample t-test.